Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 2934
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
68658
Excellent news! I thought covid impacted the
(7)
Ultimate
02/22/2021 11:44:47 AM
68657
"The Company is collaborating with a Regional
(10)
Drano
02/22/2021 11:44:07 AM
68656
10Q great news: " In January 2021, Alfasigma
(10)
Drano
02/22/2021 11:41:44 AM
68654
A phase2/3 or 3 wouldnt be possible if there
(2)
Ultimate
02/22/2021 11:19:04 AM
68651
Perhaps they are testing for other viruses also.
Fit007
02/22/2021 10:02:20 AM
68643
Maybe a ph3 with EUA in Russia. One can wonder.
(1)
zdubble17
02/22/2021 9:34:35 AM
68641
Thanks. That's one hell of an extension to end
(1)
crashco
02/22/2021 9:28:25 AM
68640
https://clinline.ru/reestr-klinicheskih-issledova
zdubble17
02/22/2021 9:26:02 AM
68638
I believe the trial has been extended
(1)
zdubble17
02/22/2021 9:24:57 AM
68634
I have been stressing on other sites that
(7)
petemantx
02/21/2021 8:02:20 PM
68633
24 days since our last press release. In a trial
(6)
Ultimate
02/21/2021 7:20:20 PM
68632
Article talking about investing in vaccines and
pizza
02/21/2021 7:01:04 PM
68631
Many past trials have shown the safety of
(8)
petemantx
02/21/2021 12:11:38 PM
68630
In my opinion,I am looking at the "developments"
(11)
Kelt
02/21/2021 11:27:07 AM
68629
https://pubmed.ncbi.nlm.nih.gov/33572467/ Dated
(1)
stocker11
02/21/2021 10:22:04 AM
68628
https://www.nytimes.com/2021/02/19/opinion/covid-
(3)
crashco
02/21/2021 7:44:43 AM
68627
Same. Most here know why I invested in 2012. So I
(3)
Commando911
02/20/2021 10:26:01 PM
68626
The link to the entire article on MicrocapDaily:
(9)
someconcerns
02/20/2021 12:24:00 PM
68625
Yes......another outstanding post by Pete!!! I
(8)
falcon74
02/20/2021 11:54:58 AM
68624
Thank you for that well thought out and inspiring
(8)
Ultimate
02/20/2021 11:38:19 AM
68623
Post I made this AM in regards to a good write up
(13)
petemantx
02/20/2021 10:22:26 AM
68620
Just a few problems for da shorts! Go
(6)
AlanC
02/19/2021 7:24:12 PM
68619
20210219|IPIX|3479462|0|5483204|O
(7)
4kids
02/19/2021 7:14:43 PM
68618
Id Refer a Mon filing than a
(4)
Commando911
02/19/2021 3:21:38 PM
68617
Classic stop-loss raid. I cannot wait IPIX to get
(3)
rocrelease
02/19/2021 2:49:53 PM
68615
Break that .48 wall today heading into the
pizza
02/19/2021 1:58:33 PM
68613
The Russian drug is PRE-CLINICAL. Please stop
(6)
Drano
02/19/2021 11:28:34 AM
68612
I think folks are conflating the Russian arm of
(1)
crashco
02/19/2021 9:41:03 AM
68611
Wasnt the commencement of the trail the same
(1)
stocker11
02/19/2021 9:26:07 AM
68610
Looks interesting but I think that a different
(6)
Ultimate
02/19/2021 12:02:43 AM
68607
Drano I believe that if it is Brilacidin, the
zdubble17
02/18/2021 11:10:05 PM
68606
Here it is. Additional formulation work is
(4)
zdubble17
02/18/2021 11:04:59 PM
68605
The Russians are claiming they have a drug that
(1)
Drano
02/18/2021 10:02:18 PM
68604
I believe there is an effort, or at least an
crashco
02/18/2021 9:58:31 PM
68603
I thought I saw in a PR that Ipix was looking
zdubble17
02/18/2021 9:41:37 PM
68602
That is funny!!!
Pipilongstocking
02/18/2021 9:30:19 PM
68600
I don't believe anything the Russians say about
(4)
Drano
02/18/2021 8:09:02 PM
68599
Russian Lead losing punch; Veronica Skvortsova
(1)
crashco
02/18/2021 7:47:42 PM
Newer
Older
Recent Articles
Coty Inc's Ongoing Investigation Brings Hope for Investors
Potential Legal Scrutiny for aTyr Pharma: Seeking Justice for Investors
Discover the Wonders of Mleiha National Park in the UAE
Trump's Bold Stance on Kimmel's Show Cancellation and Media Influence
Understanding the Effects of Fed Rate Cuts on Your Finances
Telenor Sweden and Mycom Enhance 5G Experience with Renewal
AtlasClear Holdings Rises 15% After Successful Financing Round
Sungrow Partners with EP Produzione for Major Battery Project
Rubenstein Law Achieves Significant Win in Slip and Fall Case
Exploring China’s Expanding Economic Footprint in Africa
Google Workspace: The Leading AI Assistant for Productivity
Payentry Partners with Equifax for Enhanced Employment Verification
MEDIPEEL's Europe Expansion Strategy Boosts Global Presence
Telenor Sweden and Mycom Strengthen Partnership for 5G Success
PotisEdge Introduces Innovative Energy Storage Solutions
Courageous Canadian Pilots Provide Hope Amidst Conflict
AXIL Brands Expands Reviv3 Procare Product Line with Chatters
InterDigital Welcomes Julia C. Mattis as New Chief Licensing Officer
Norðurþing Reports 2025 Financial Performance Overview
Sompo International Welcomes Alessandrea Quane as New CEO
Novo Nordisk Reveals Ozempic® Breakthrough Study Results
Investors Eye S&P 500 Gains as Fed Cuts Rates and Recession Feared
iHuman Inc. Shares Q2 2025 Financial Performance Insights
Upcoming Earnings: Key Financial Insights for Investors
Investors Seek Justice Against Fly-E Group for Securities Fraud
Savara Inc. Faces Class Action Over Alleged Securities Fraud
Legal Opportunities Emerges for SelectQuote, Inc. Investors
Digital Intelligence Era Boosts International Arbitration Initiatives
Investors Urged to Join KBR, Inc. Fraud Investigation Today
Rapidtek Unveils FoldSAT Portable LEO Terminal for Future Use
Alessandrea Quane Takes the Helm as CEO of Sompo's International Markets
Julia C. Mattis Takes Charge as Chief Licensing Officer at InterDigital
Investors Alert: Investigating Sable Offshore Corp. Securities Issues
Celebrating a Cultural Icon: Lan Su Chinese Garden's Legacy
iHuman Inc. Reports Strong Q2 Results with Innovative Growth
Explore a Unique Summer Institute Focused on Eastern Europe
Projecting Future Growth of Digital Process Automation Market
Important Insights on Recent Transactions by Dowlais Group
Epitopea's Scientific Advisory Board Welcomes New Experts
iHuman and Cricket Media Join Forces for Reading Revolution
GriefShare Unveils Digital Resources for Global Support Expansion
Women in Fintech: Bridging the Gender Gap at TOKEN2049
Clarivate Unveils Comprehensive 2024 Sustainability Achievements
Wolters Kluwer's Recent Share Buyback Efforts Explained
Insights into Treatt plc's Principal Trader Activities
Kitron ASA Has Increased Share Capital Through New Issue
Equinor ASA Announces Buy-Back Programme for Employee Shares
NCC Group plc: Latest Regulatory Disclosure Update
Exploring the Legacy and Innovations of Questex's R&R Forum
Insights on Meta's AR/VR Challenges and Apple's Strategic Advantage